Nuplazid is a medication used to treat Parkinson’s disease psychosis. It’s been proven to improve symptoms such as hallucinations and delusions, but who makes it? In this article, we’ll explore the company behind Nuplazid and the research and development that has gone into this groundbreaking medication. We’ll also discuss the potential risks and benefits of taking Nuplazid and how it could help those with Parkinson’s. So, if you’re looking for more information on Nuplazid and who makes it, keep reading!
Nuplazid is manufactured by Acadia Pharmaceuticals Inc., a biopharmaceutical company based in San Diego, California. The company specializes in developing and delivering treatments for central nervous system disorders. Nuplazid is approved by the FDA for the treatment of Parkinson’s disease psychosis.
Who Makes Nuplazid?
Nuplazid (pimavanserin) is a prescription drug used to treat hallucinations and delusions associated with Parkinson’s disease psychosis. The medication was developed and is marketed by ACADIA Pharmaceuticals, Inc., a biopharmaceutical company based in San Diego, California.
History of ACADIA Pharmaceuticals
ACADIA Pharmaceuticals was founded in 1993 to develop treatments for central nervous system disorders such as schizophrenia, depression, Parkinson’s disease, and other neurological and psychiatric disorders. The company has offices in San Diego and in Toronto, Canada.
Nuplazid Development and Approval
Nuplazid was developed by ACADIA Pharmaceuticals and approved by the U.S. Food and Drug Administration (FDA) in 2016. It is the first and only medication approved by the FDA for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. The drug is available in the form of a tablet that is taken orally once a day.
Other Drugs Developed by ACADIA Pharmaceuticals
In addition to Nuplazid, ACADIA Pharmaceuticals has developed several other drugs, including:
- Pimavanserin – a drug used to treat patients with Parkinson’s disease psychosis.
- Naratriptan – a drug used to treat acute migraine headache.
- Riluzole – a drug used to treat amyotrophic lateral sclerosis (ALS).
- Vilazodone – a drug used to treat major depressive disorder.
- Beloranib – an experimental drug being studied for the treatment of obesity.
Related FAQ
Q1: Who Makes Nuplazid?
A1: Nuplazid is produced by Acadia Pharmaceuticals, a biopharmaceutical company based in San Diego, California. Founded in 1993, Acadia is focused on the development and commercialization of small molecule drugs for diseases of the central nervous system and other disorders. Nuplazid is the first and only FDA-approved medicine for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. Acadia is researching other potential uses for Nuplazid, including the treatment of schizophrenia.
Q2: What is the active ingredient in Nuplazid?
A2: Nuplazid is an atypical antipsychotic medication that contains the active ingredient pimavanserin. This compound works by blocking a certain type of serotonin receptor in the brain that is linked to psychosis. It is believed that by blocking this receptor, Nuplazid can reduce symptoms of psychosis, such as hallucinations and delusions.
Q3: How is Nuplazid administered?
A3: Nuplazid is administered orally in tablet form. It is typically taken once a day, with or without food. The recommended dose is 34 mg taken once a day. It is important to take Nuplazid exactly as prescribed by your doctor. Do not take more or less than your prescribed dose.
Q4: Are there any special considerations when taking Nuplazid?
A4: Yes, it is important to talk to your doctor about any other medications you are taking before starting Nuplazid. Certain medications can interact with Nuplazid and should not be taken together. It is also important to tell your doctor if you have any allergies or pre-existing medical conditions, as these could affect your ability to take Nuplazid safely.
Q5: What side effects are associated with Nuplazid?
A5: Common side effects associated with Nuplazid include dizziness, drowsiness, nausea, constipation, dry mouth, stomach upset, and headache. More serious side effects may include increased risk of falls, abnormal muscle movements, and changes in behavior or thinking. It is important to report any side effects to your doctor immediately.
Q6: What should I do if I miss a dose of Nuplazid?
A6: If you miss a dose of Nuplazid, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and take your next dose at its regularly scheduled time. Do not take double doses of Nuplazid to make up for a missed dose.
Conclusion
Nuplazid is a revolutionary medication that is helping patients with Parkinson’s disease psychosis. Pioneered by Acadia Pharmaceuticals and approved by the FDA, it is the first medication approved specifically for this condition. With its unique ability to reduce the symptoms of psychosis without causing unpleasant side effects, it has been a welcome addition to the treatment of Parkinson’s disease. With the help of Acadia’s advances in medical technology, Nuplazid is set to revolutionize the way this condition is treated and offer hope to those who suffer from it.